Ron Martell insider trades
Open-market stock purchases and sales by Ron Martell, President, CEO and Director at Jasper Therapeutics, Inc, from SEC Form 4 filings since Feb 4, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -83%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | JSPR Jasper Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- JSPR Jasper Therapeutics, Inc: 1 buy, last Jan 2, 2026
- CTYX Cytori Therapeutics, Inc: other filings, last Jan 26, 2017
- KBIO Kalobios Pharmaceuticals Inc: other filings, last Oct 28, 2015
- SVON Sevion Therapeutics, Inc: other filings, last Nov 18, 2014
- SNTI Senesco Technologies Inc: other filings, last Jun 25, 2014
- NGSX NeurogesX Inc: other filings, last Jan 1, 2013
- PARD Poniard Pharmaceuticals, Inc: 2 buys, last Oct 6, 2011